Meeting
2023 ASCO Annual Meeting
Diagnostic application of circulating CDH17 biomarker for screening GI malignancies.
Authors
Lui Ng
The University of Hong Kong, Pokfulam, Hong Kong
Lui Ng , Deepak Iyer , Tony K Wong , Tsz Chun Hon , Stella Sun , John Moon Luk , Dominic Chi-Chung Foo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3058)
DOI
10.1200/JCO.2023.41.16_suppl.3058
Abstract #
3058
Poster Bd #
256
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Use of glycoproteome profiles to detect advanced adenomas and colorectal cancer.
First Author: Khushbu Desai
Poster
2020 Gastrointestinal Cancers Symposium
Integrating multiple “omics” analyses, on a triage concept, for effective case selection followed by diagnostic colonoscopy.
First Author: Sheeno P. Thyparambil
Poster
2023 ASCO Quality Care Symposium
Biomarker testing rates among metastatic cancer patients with receipt of anti-cancer systemic therapy: A real-world data analysis.
First Author: Stacey DaCosta Byfield
Poster
2023 ASCO Annual Meeting
Neoplasia detection via colonoscopic surveillance among young patients with MSH6 and PMS2-associated Lynch syndrome.
First Author: Alicia Latham